Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (211-220 of 561) with videos related to

Pageof 57
Sort By:
Prostate Cancer and Prostatic Diseases|April 13, 2023
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapyLuca Afferi, Mattia Longoni, Marco Moschini, et al.
European Urology Oncology|September 27, 2024
Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical OverviewLuca Afferi, Andrea Gallioli, Damiano Stracci, et al.
Scandinavian Journal of Urology|January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancerMarco Moschini, Vidit Sharma, Matteo Soligo, et al.
World Journal of Urology|August 30, 2019
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissectionStefania Zamboni, Marco Moschini, Alessandro Antonelli, et al.
Minerva Urology and Nephrology|September 2, 2025
The current role of photodynamic diagnosis (PDD) in the management of non-muscle invasive bladder cancer: the Italian Society of Urology (SIU) Position PaperFrancesco Soria, Andrea Mari, Marco Moschini, et al.
The Journal of Urology|November 14, 2019
Reply by AuthorsRafael R Tourinho-Barbosa, Rafael Sanchez-Salas, Oliver Rojas Claros, et al.
The Journal of Urology|September 28, 2016
Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate CancerEmanuele Zaffuto, Giorgio Gandaglia, Nicola Fossati, et al.
Urologic Oncology|January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Urologic Oncology|December 10, 2016
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemesMarco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, et al.
Translational Andrology and Urology|October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohortGiancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
Pageof 57

Showing results (211-220 of 561) with videos related to

Sort By:
Pageof 57
Prostate Cancer and Prostatic Diseases|April 13, 2023
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapyLuca Afferi, Mattia Longoni, Marco Moschini, et al.
European Urology Oncology|September 27, 2024
Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical OverviewLuca Afferi, Andrea Gallioli, Damiano Stracci, et al.
Scandinavian Journal of Urology|January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancerMarco Moschini, Vidit Sharma, Matteo Soligo, et al.
World Journal of Urology|August 30, 2019
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissectionStefania Zamboni, Marco Moschini, Alessandro Antonelli, et al.
Minerva Urology and Nephrology|September 2, 2025
The current role of photodynamic diagnosis (PDD) in the management of non-muscle invasive bladder cancer: the Italian Society of Urology (SIU) Position PaperFrancesco Soria, Andrea Mari, Marco Moschini, et al.
The Journal of Urology|November 14, 2019
Reply by AuthorsRafael R Tourinho-Barbosa, Rafael Sanchez-Salas, Oliver Rojas Claros, et al.
The Journal of Urology|September 28, 2016
Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate CancerEmanuele Zaffuto, Giorgio Gandaglia, Nicola Fossati, et al.
Urologic Oncology|January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Urologic Oncology|December 10, 2016
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemesMarco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, et al.
Translational Andrology and Urology|October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohortGiancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
Pageof 57